Form 4: Core Scientific Director Receives RSU Grant

Director Stephen M. Smith was granted 18,961 restricted stock units as part of his compensation package.

Summary

• Director Stephen M. Smith acquired 18,961 restricted stock units (RSUs) of Core Scientific, Inc. (CORZ).
• The transaction occurred on May 26, 2026.
• The RSUs were granted at a price of $0 per share as part of equity compensation.
• The total beneficial ownership following this transaction is 18,961 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• Potential for future dilution of existing shareholders upon the vesting and issuance of the underlying common stock.

Risks

• Vesting is contingent upon the continued service of the director to the issuer.

Future Outlook

The RSUs will vest in two substantially equal installments on May 26, 2027, and May 26, 2028, subject to continued service.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the technology and digital asset mining sectors to ensure leadership retention and alignment with shareholder interests.

Comparison to Industry Standards

• The use of multi-year vesting schedules for director equity is consistent with standard corporate governance practices for publicly traded companies.

Stakeholder Impact

• Shareholders may experience minor dilution upon the eventual conversion of RSUs into common stock.

Next Steps

• Vesting of the first 50% of RSUs on May 26, 2027.
• Vesting of the final 50% of RSUs on May 26, 2028.

Key Dates

Keywords

Core Scientific, CORZ, Form 4, Insider Trading, Restricted Stock Units, Director Compensation